MX2021010289A - Oligosacaridos de leche humana para uso en el mejoramiento de la funcion ejecutiva. - Google Patents

Oligosacaridos de leche humana para uso en el mejoramiento de la funcion ejecutiva.

Info

Publication number
MX2021010289A
MX2021010289A MX2021010289A MX2021010289A MX2021010289A MX 2021010289 A MX2021010289 A MX 2021010289A MX 2021010289 A MX2021010289 A MX 2021010289A MX 2021010289 A MX2021010289 A MX 2021010289A MX 2021010289 A MX2021010289 A MX 2021010289A
Authority
MX
Mexico
Prior art keywords
human milk
infant
executive function
milk oligosaccharides
hmo
Prior art date
Application number
MX2021010289A
Other languages
English (en)
Inventor
Bruce Mcconnell
Jonas Hauser
Louise Kristine Vigsnæs
Nora Schneider
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom As filed Critical Glycom As
Publication of MX2021010289A publication Critical patent/MX2021010289A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides

Abstract

El uso de un oligosacárido de leche humana (HMO, por sus siglas en inglés) o una composición nutricional que comprende un oligosacárido de leche humana para mejorar la función ejecutiva de un no infante, para prevenir y/o reducir el riesgo de la función ejecutiva sub-óptima en un no infante para administrar el funcionamiento ejecutivo sub-óptimo en un no infante y/o mejorar la mielinización para madurar la región de la corteza pre frontal del cerebro en un no infante, así como las composiciones sintéticas de los HMOs y los paquetes que comprenden al menos 14 dosis individuales diarias de una cantidad efectiva de al menos uno de los HMO para tal uso.
MX2021010289A 2019-03-05 2020-03-05 Oligosacaridos de leche humana para uso en el mejoramiento de la funcion ejecutiva. MX2021010289A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19160876 2019-03-05
EP19161023 2019-03-06
EP19214414 2019-12-09
DKPA201901446 2019-12-09
PCT/IB2020/051904 WO2020178774A1 (en) 2019-03-05 2020-03-05 Human milk oligosaccharides for use in enhancing executive function

Publications (1)

Publication Number Publication Date
MX2021010289A true MX2021010289A (es) 2022-02-10

Family

ID=72338226

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010289A MX2021010289A (es) 2019-03-05 2020-03-05 Oligosacaridos de leche humana para uso en el mejoramiento de la funcion ejecutiva.

Country Status (9)

Country Link
US (1) US20220160013A1 (es)
EP (1) EP3934657A4 (es)
JP (1) JP2022523560A (es)
KR (1) KR20210136059A (es)
CN (1) CN113825516A (es)
AU (1) AU2020231116A1 (es)
BR (1) BR112021016924A2 (es)
MX (1) MX2021010289A (es)
WO (1) WO2020178774A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023006135A (es) * 2020-12-04 2023-06-06 Glycom As Oligosacaridos de leche humana para uso en el apoyo a la maduracion o la mejora de los patrones de sue?o.
GB202114190D0 (en) * 2021-10-04 2021-11-17 Mjn Us Holdings Llc Compositions for preventing and/or treating demyelination
KR102527378B1 (ko) * 2022-04-28 2023-05-02 (주)에이피테크놀로지 2'-fl을 함유하는 도파민 감소로 말미암아 발생하는 질환의 개선, 예방 또는 치료용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013016914A2 (pt) * 2010-12-31 2019-09-24 Abbott Lab combinação simbiótica de probióticos e oligossacarídeos do leite humano para promover o crescimento de microbiota benéfica
ES2795665T3 (es) * 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
EP2888950A1 (en) * 2013-12-24 2015-07-01 Abbott Laboratories Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
CN108289492A (zh) * 2015-12-15 2018-07-17 雀巢产品技术援助有限公司 Hmo的混合物
KR20180099885A (ko) * 2016-01-13 2018-09-05 주식회사 베네비오 Pgc-1알파의 발현을 증가시키는 조성물
KR102502459B1 (ko) * 2016-07-28 2023-02-21 폰테라 코-오퍼레이티브 그룹 리미티드 유제품과 방법
EP3629768A1 (en) * 2017-05-24 2020-04-08 Société des Produits Nestlé S.A. A nutritional composition for use to enhance attention and/or reduce impulsivity
CN110799045A (zh) * 2017-05-24 2020-02-14 雀巢产品有限公司 用于改善短期记忆和其他认知益处的包含人乳低聚糖(hmo)的组合物

Also Published As

Publication number Publication date
AU2020231116A1 (en) 2021-09-23
EP3934657A4 (en) 2023-01-04
JP2022523560A (ja) 2022-04-25
US20220160013A1 (en) 2022-05-26
KR20210136059A (ko) 2021-11-16
CN113825516A (zh) 2021-12-21
EP3934657A1 (en) 2022-01-12
WO2020178774A1 (en) 2020-09-10
BR112021016924A2 (pt) 2021-11-03

Similar Documents

Publication Publication Date Title
MX2021010289A (es) Oligosacaridos de leche humana para uso en el mejoramiento de la funcion ejecutiva.
PH12016500762A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
MD3788045T2 (ro) Compuși inhibitori ai RIP1 și procedee de obţinere și utilizare a acestora
PH12018501297A1 (en) Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
WO2002040051A1 (en) Colostrum-based composition
PH12019500799A1 (en) Personalized pediatric nutrition products comprising human milk oligosaccharides
AU2021269317B2 (en) Treatment for gingivitis
MX2021012894A (es) Compuestos ciclicos de fosfato.
WO2015048503A3 (en) N-arylmethyl sulfonamide negative modulators of nr2a
CN101112463A (zh) 蓝莓果和葡萄籽与维生素c和e配伍的组合物
CN102949699A (zh) 一种治疗气滞胃痛的中药
MX2023006261A (es) Composiciones que comprenden oligosacaridos de la leche humana para uso en un sujeto para apoyar la duracion del sue?o nocturno.
JOP20190275A1 (ar) طرق وتركيبات لعلاج اضطراب إسهال خِلقي
ZA202109829B (en) Super-oxide dismutase soluble fiber compositions
CN106804729A (zh) 一种改善智力的中老年配方奶粉
CN106107300A (zh) 一种富含维生素的饮用水
CN106474294A (zh) 一种酵素消毒液
MX2021010210A (es) Una composicion nutricional para usar para mejorar la funcion ejecutiva.
Papageorgiou et al. The Effects of Short-Term Low Energy Availability on Bone Turnover in Men: 1537 May 28, 1: 30 PM-1: 45 PM
MX2022006411A (es) Composiciones que comprenden oligosacaridos de la leche humana para uso en un sujeto para apoyar el desarrollo del lenguaje.
CN107641249A (zh) 一种甩脂机塑料外壳
CN108066486A (zh) 一种养肝明目口服液
MX2021005669A (es) Metodos para mejorar la salud metabolica en un animal.
PH12014502014B1 (en) Animal feed composition containing encapsulated glucono delta-lactone